mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |